Tumor-infiltrating lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tumor-infiltrating lymphocytes, covering 2016-10-18 to 2016-10-18. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC [Phase 2]